全文获取类型
收费全文 | 108950篇 |
免费 | 7444篇 |
国内免费 | 2814篇 |
专业分类
耳鼻咽喉 | 550篇 |
儿科学 | 2824篇 |
妇产科学 | 2223篇 |
基础医学 | 16955篇 |
口腔科学 | 2078篇 |
临床医学 | 6490篇 |
内科学 | 18849篇 |
皮肤病学 | 1687篇 |
神经病学 | 12792篇 |
特种医学 | 2771篇 |
外国民族医学 | 22篇 |
外科学 | 9879篇 |
综合类 | 10172篇 |
预防医学 | 4534篇 |
眼科学 | 1004篇 |
药学 | 16459篇 |
30篇 | |
中国医学 | 2234篇 |
肿瘤学 | 7655篇 |
出版年
2023年 | 1304篇 |
2022年 | 1787篇 |
2021年 | 3152篇 |
2020年 | 3238篇 |
2019年 | 4106篇 |
2018年 | 4027篇 |
2017年 | 3409篇 |
2016年 | 2977篇 |
2015年 | 3324篇 |
2014年 | 5706篇 |
2013年 | 7014篇 |
2012年 | 5174篇 |
2011年 | 5903篇 |
2010年 | 4884篇 |
2009年 | 5127篇 |
2008年 | 5259篇 |
2007年 | 4833篇 |
2006年 | 4260篇 |
2005年 | 3630篇 |
2004年 | 3369篇 |
2003年 | 3099篇 |
2002年 | 2452篇 |
2001年 | 2187篇 |
2000年 | 1962篇 |
1999年 | 1697篇 |
1998年 | 1649篇 |
1997年 | 1540篇 |
1996年 | 1286篇 |
1995年 | 1222篇 |
1994年 | 1123篇 |
1993年 | 962篇 |
1992年 | 751篇 |
1991年 | 710篇 |
1990年 | 543篇 |
1989年 | 469篇 |
1988年 | 418篇 |
1986年 | 373篇 |
1985年 | 1366篇 |
1984年 | 2101篇 |
1983年 | 1286篇 |
1982年 | 1478篇 |
1981年 | 1390篇 |
1980年 | 1122篇 |
1979年 | 977篇 |
1978年 | 859篇 |
1977年 | 729篇 |
1976年 | 824篇 |
1975年 | 589篇 |
1974年 | 511篇 |
1973年 | 563篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
埃克替尼联合抗血管药物一线治疗EGFR突变晚期肺腺癌的单中心研究 《首都医科大学学报》2022,43(2):289-293
目的 观察埃克替尼联合抗血管药物一线治疗表皮生长因子受体(epidermal growth factor receptor,EGFR)突变晚期肺腺癌的治疗效果和不良反应。方法 选取首都医科大学宣武医院胸科2018年6月1日至2019年12月31日期间,37例EGFR突变晚期肺腺癌的患者。采用埃克替尼(125 mg/次,3 次/d)联合贝伐单抗(7.5 mg/kg,1次/3周);或埃克替尼(125 mg/次,3 次/d)联合安罗替尼(10~12 mg 1次/d,第1~14天),均21 d为1个周期,至疾病进展或出现严重的不良反应后终止。中位随访时间14.5(9.2~30.8)个月。结果 本组患者中,62.2%(23/37)达到部分缓解,37.8% (14/37) 达到疾病稳定。客观有效率为62.2%(23/37),疾病控制率为100%(37/37)。中位疾病无进展时间为17.9个月(95% CI:10.292~25.508)个月。1年生存率为83.8%,18个月生存率为81.1%。多因素Cox回归分析结果显示,肝转移和脑转移对患者的PFS有明显影响(P<0.05)。最常见不良反应为皮疹(43.2%, 16/37)和腹泻(21.6%, 8/37)。结论 埃克替尼联合抗血管药物是一种有效且安全的一线治疗EGFR突变晚期肺腺癌的方案。 相似文献
2.
3.
目的探讨胸部孤立性纤维性肿瘤(SFT)的多层螺旋CT影像学表现与组织标本人表皮生长因子受体2(CerbB-2)表达的相关性。方法收集手术治疗的SFT的34例患者临床资料,术前均行多层螺旋CT检查,切除肿瘤组织标本采用免疫组织化学SP法对CerbB-2表达进行检测,分析结果。结果在多层螺旋CT下肿瘤形态13例(38.24%)为圆形或椭圆形、18例(52.94%)为不规则形、3例(8.82%)为分叶状,30例(88.24%)肿瘤组织边缘清晰、4例(11.76%)边缘不清,12例(35.29%)CT平扫及强化扫描肿瘤密度均均匀,22例(64.71%)平扫和强化扫描不均匀有不规则钙化或病灶坏死。肿瘤最大直径4.72~22 cm,平均为(13.34±4.36)cm,肿瘤实质平扫CT值(35.79±8.33)HU,肿瘤实质增强CT值(66.47±21.56)HU,静脉期最大强化率(vCER)(155.24±45.72)%。26患者切除肿瘤组织中CerbB-2表达阳性,阳性率为76.47%,其中弱阳性7例、中等阳性11例、强阳性8例。瘤细胞密度(438.95±103.47)个,肿瘤实质血管数(2.41±0.74)条。患者多层螺旋CT检查所示的肿瘤直径、肿瘤平扫及增强扫描CT值、静脉期vCER不同时CerbB-2表达阳性率明显不同,比较差异有统计学意义(P<0.05)。Spearman相关分析显示患者多层螺旋CT检查所示肿瘤直径、肿瘤平扫及增强扫描CT值、静脉期vCER值与肿瘤组织中CerbB-2表达阳性率之间有正相关性(P<0.05)。结论胸部SFT在多层螺旋CT下主要表现为边缘清晰、不均匀强化的圆形或椭圆形包块,组织CerbB-2表达阳性率高。多层螺旋CT影像学指标与肿瘤组织CerbB-2蛋白有密切相关性。 相似文献
4.
胃癌作为临床最常见的肿瘤之一,常因确诊疾病较晚而影响治疗效果,胃镜活检后的病理虽然作为确诊的金标准,但是由于此方式过程痛苦,操作复杂,费用较高,且具有侵入性,可能会导致患者拒绝操作而难普及于临床,因此积极找寻胃癌有效的监测指标十分必要。近年来,很多学者研究维生素与胃癌的相关关系,并试图通过摄取某些维生素降低胃癌发生率,延缓病情及改善预后,也有通过检测血清中维生素的水平给早期胃癌的诊断提供帮助。本文就同型半胱氨酸、维生素D、维生素C、维生素E、维生素B12及叶酸在胃癌中的作用机制,及其在血清中水平与胃癌关系的相关研究进展进行简要综述,为临床胃癌诊疗提供新思路。 相似文献
5.
《Dental materials》2022,38(9):1459-1469
ObjectiveTo evaluate the manufacturing accuracy of zirconia four-unit fixed dental prostheses (FDPs) fabricated by three different additive manufacturing technologies compared with subtractive manufacturing.MethodsA total of 79 zirconia FDPs were produced by three different manufacturing technologies, representing additive (one stereolithography [aSLA] and one material jetting [aMJ] device, two digital light processing [aDLP1/aDLP2] devices) and subtractive manufacturing (two devices [s1/s2]), the latter serving as references. After printing, additively manufactured FDPs were debound and finally sintered. Subsequently, samples were circumferentially digitized and acquired surface areas were split in three Regions Of Interest (ROIs: inner/outer shell, margin). Design and acquired data were compared for accuracy using an inspection software. Statistical evaluation was performed using the root mean square error (RMSE) and nonparametric Kruskal-Wallis method with post hoc Wilcoxon-Mann-Whitney U tests. Bonferroni correction was applied in case of multiple testing.ResultsRegardless the ROI, significant differences were observed between manufacturing technologies (P < 0.001). Subtractive manufacturing was the most accurate with no significant difference regarding the material/device (s1/s2, P > 0.054). Likewise, no statistical difference regarding accurary was found when comparing s2 with aMJ and aSLA in most ROIs (P > 0.085). In general, mean surface deviation was< 50 µm for s1/s2 and aMJ and< 100 µm for aSLA and aDLP2. aDLP1 showed surface deviations> 100 µm and was the least accurate compared to the other additive/subtractive technologies.SignificanceAdditive manufacturing represents a promising set of technologies for the manufacturing of zirconia FDPs, but not yet as accurate as subtractive manufacturing. Methodological impact on accuracy within and in between different additive technologies needs to be further investigated. 相似文献
6.
目的 观察过氧化物酶体增殖物活化受体 γ (PPAR-γ) 过表达对大鼠肾缺血再灌注 (RI/ R) 损
伤的保护作用, 并探讨其作用机制。 方法 将 40 只 SD 大鼠随机分为对照组、 RI/ R 模型组、 RI/ R + LV 组
和 RI/ R + PPAR-γ 组, 10 只/ 组, 采用手术阻断双侧肾动脉血流构建 RI/ R 损伤模型; RI/ R + PPAR-γ 组于
恢复再灌注前经尾静脉注射 PPAR-γ 重组慢病毒载体, RI/ R + LV 组注射含有空质粒的慢病毒载体, RI/ R
模型组注射等量生理盐水。 再灌注结束后, 通过 HE 和 Masson 染色观察肾组织病理改变; 全自动生化分析
仪检测尿蛋白、 血肌酐 ( Scr)、 血尿素氮 ( BUN) 水平; ELISA 法检测血清和肾组织肿瘤坏死因子 α
(TNF-α)、 白介素 6 ( IL-6) 含量; RT-PCR 检测肾组织 PPAR-γ mRNA 表达; 蛋白质印迹法检测肾组织
PPAR-γ、 转化生长因子 β (TGF-β)、 α 平滑肌肌动蛋白 (α-SMA)、 纤维连接蛋白 (FN) 以及凋亡相关蛋
白 Bax、 Bcl-2、 caspase-3、 Cleaved caspase-3、 caspase-9、 Cleaved caspase-9 表达。 结果 与对照组比较, RI/
R 模型组 PPAR-γ 水平降低 (P< 0. 05), 尿蛋白、 Scr、 BUN、 TNF-α、 IL-6、 Bax / Bcl-2、 Cleaved caspase-3 /
caspase-3、 Cleaved caspase-9 / caspase-9、 TGF-β、 α-SMA、 FN 水平升高 (P< 0. 05)。 与 RI/ R 模型组比较,
RI/ R + PPAR-γ 组 PPAR-γ 水平升高 ( P< 0. 05), 尿蛋白、 Scr、 BUN、 TNF-α、 IL-6、 Bax / Bcl-2、 Cleaved
caspase-3 / caspase-3、 Cleaved caspase-9 / caspase-9、 TGF-β、 α-SMA、 FN 水平降低 (P< 0. 05)。 结论 过表
达 PPAR-γ 可通过减少促炎细胞因子释放, 改善肾纤维化而减少 RI/ R 损伤。 相似文献
7.
《Journal of microbiology, immunology, and infection》2022,55(2):273-281
BackgroundStenotrophomonas maltophilia, a species of highly genetic diversity, has emerged as an important nosocomial pathogen. S. maltophilia and Pseudomonas aeruginosa are often co-isolated from pneumonia patients. In our previous study, we have demonstrated that the pacIRA cluster present in some but not all clinical S. maltophilia isolates. Proteins encoded by pacIRA operon are an extracytoplasmic function (ECF) sigma factor, a transmembrane anti-sigma regulator, and a TonB-dependent receptor. This study aimed to elucidate PacIRA system function and its significance to S. maltophilia.MethodsThe pacI, pacR, and pacA genes were individually or totally deleted from the chromosome of KJΔEnt, a pacIRA-positive and siderophore-null strain. Growth promotion assay was performed to examine the implication of pacIRA system in iron utilization. Gene expression was quantified by quantitative real time PCR (qRT-PCR). Growth competition assay was executed to investigate the significance of pacIRA operon to S. maltophilia.ResultsPacIRA system contributed to utilize ferri-pyochelin of P. aeruginosa as iron sources for growth in an iron-depleted condition, but hardly utilized ferric citrate, hemin, ferri-stenobactin, and ferri-pyoverdine. PacIRA was founded to belong to Fur regulon and upregulated in response to iron-depleted stress. Growth competition assay demonstrated that pacIRA-positive S. maltophilia had a superiority over pacIRA-negative S. maltophilia in iron acquisition when they were co-cultured in P. aeruginosa ferri-pyochelin-supplemented medium.ConclusionsPacIRA system of S. maltophilia is a xenosiderophore uptake implement, involving in the acquisition of pyochelin of P. aeruginosa. 相似文献
8.
9.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(1):21-31
AimThis review aims to summarize and discuss some of the most relevant clinical trials in epidemiology, diagnostics, and treatment of hypertension published in 2020 and 2021.Data synthesisThe trials included in this review are related to hypertension onset age and risk for future cardiovascular disease, reliability of different blood pressure monitoring methods, role of exercise-induced hypertension, treatment of hypertension in patients with SARS-CoV-2 infection, management of hypertension high-risk patient groups, e.g., in the elderly (≥80 years) and patients with atrial fibrillation, and the interplay between nutrition and hypertension, as well as recent insights into renal denervation for treatment of hypertension.ConclusionsHypertension onset age, nighttime blood pressure levels and a riser pattern are relevant for the prognosis of future cardiovascular diseases. The risk of coronary heart disease appears to increase linearly with increasing exercise systolic blood pressure. Renin-angiotensin system blockers are not associated with an increased risk for a severe course of COVID-19. In elderly patients, a risk-benefit assessment of intensified blood pressure control should be individually evaluated. A J-shaped association between cardiovascular disease and achieved blood pressure could also be demonstrated in patients with atrial fibrillation on anticoagulation. Salt restriction and lifestyle modification remain effective options in treating hypertensive patients at low cardiovascular risk. Sodium glucose co-transporter 2 inhibitors and Glucagon-like peptide-1 receptor agonists show BP-lowering effects. Renal denervation should be considered as an additional or alternative treatment option in selected patients with uncontrolled hypertension. 相似文献
10.